http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2741870-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3f2510cb419d90b66eabe157e30a659
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D301-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D301-12
filingDate 2020-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9a4fdc2c7b7395aa702fe45df143e64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95db2673e85cc68aa995d8e62df9d707
publicationDate 2021-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2741870-C1
titleOfInvention Method of producing crystalline form of cis-2,3-epoxy succinate calcium
abstract FIELD: chemistry.SUBSTANCE: invention relates to production of metal carboxylates. In particular, the invention relates to production of a new crystalline form of cis-2,3-epoxy succinate calcium (salts of 2,3-epoxy-1,4-butanedioic acid) and is a raw material for obtaining L - (+) - tartaric acid. Method of producing the crystalline modification of cis-2,3-epoxy succinate calcium involves the following steps: a) partial neutralization of maleic acid or maleic anhydride with a first portion of a calcium compound to obtain acidic calcium maleate; b) epoxidation of acidic calcium maleate with hydrogen peroxide in the presence of epoxidation catalysts to obtain acid cis-2,3-epoxy succinate calcium; c) neutralizing the acid cis-2,3-epoxy succinate calcium by adding a second portion of the calcium compound; d) holding cis-2,3-epoxy succinate calcium for 24 to 240 hours to obtain a crystalline form of cis-2,3-epoxy succinate calcium, where the crystals belong to the space group P21/n, wherein the crystal lattice parameters at 22 °C area= 15.1916 (2) Å, b = 8.9121 (1) Å, c = 7.4724 (1) Å, beta = 103.309 (1)°, where step (b) epoxidation is carried out at a pH value not higher than 3.EFFECT: technical result is obtaining a crystalline form of cis-2,3-epoxy succinate calcium with content of D-tartaric acid (by-product) of 1.2 % and less, with pH of epoxidation stage not higher than 3.75 cl, 4 tbl, 5 dwg
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021194384-A1
priorityDate 2020-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1423028-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105753818-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1534195-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2658838-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447730363
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408187907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14778
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419575953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524006
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448569415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6093208
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452610125
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449202744
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447471035
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451191405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453986024
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13538056
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449307628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447730362
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425762086
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176262
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447659899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453721531
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID150191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26052
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452890905
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457765275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453467280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13725892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444787
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23964
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6916005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73851534
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID784
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61424
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82208
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408499458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419405613

Total number of triples: 70.